The state of California has issued a cease-and-desist order to a compounding business run by AmerisourceBergen (ABC), one of the nation’s largest pharmaceutical wholesalers, and the move could jeopardize a key license the company holds in the state.

The order was issued to Pharmedium Services, which the wholesaler bought in 2015, after an inspection by the state Board of Pharmacy found more than a dozen violations of federal law. These included failing to test components and to place dosage and usage instructions on labels. The compounder was also cited for assigning expiration dates for compounded medicines without “sound scientific support.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy